Medigene (FRA: MDG1)

Last close As at 07/10/2025

EUR0.13

−0.05 (−27.57%)

Market capitalisation

Medigene is a publicly listed, Germany-based, immuno-oncology platform company focused on the development of T cell receptor (TCR)-guided therapies with the aim of effectively eliminating cancer.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Dr Gerd Zettlmeissl

    Chairman

  • Dr Selwyn Ho

    CEO

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free